PI3K/AKT/mTOR Signaling-Mediated Neuropeptide VGF in the Hippocampus of Mice Is Involved in the Rapid Onset Antidepressant-Like Effects of GLYX-13
Author(s) -
Lu Yang,
Chuang Wang,
Zhancheng Xue,
Chenli Li,
Junfang Zhang,
Xin Zhao,
Aiming Liu,
Qinwen Wang,
Wenhua Zhou
Publication year - 2015
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyu110
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , behavioural despair test , ly294002 , hippocampus , phosphatidylinositol , neuroprotection , kinase , antidepressant , endocrinology , pharmacology , signal transduction , medicine , biology , microbiology and biotechnology
VGF (nonacryonimic) and phosphatidylinositol 3-kinase (PI3K)/AKT (also known as protein kinase B, PKB)/mammalian target of rapamycin (mTOR) signaling play pivotal roles in depression. However, whether phosphatidylinositol 3-kinase/AKT/mTOR signaling-mediated VGF participates in rapid-acting antidepressant-like actions of GLYX-13 is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom